Perioperative morbidity of open retroperitoneal lymph node dissection for testicular germ cell tumors: an in-depth single center analysis according to European Association of Urology guidelines of complication reporting and a scoping literature review
Klemm J, Dahlem R, Hartmann M, von Deimling M, Schulz R, Klemm D, Janisch F, Shariat S, Fisch M, Vetterlein M
SURG ONCOL. 2025 [Epub ahead of print];60:102228.

Definitions, outcomes and perspectives for oligometastatic bladder cancer: towards a standardized terminology
Calleris G, von Deimling M, Kesch C, Soria F, Gontero P, Ploussard G, Laukhtina E, Pradere B
CURR OPIN UROL. 2024;34(3):217-224.

Loss of postnatal Arx transcriptional activity in parvalbumin interneurons reveals non-cell autonomous disturbances in CA1 pyramidal cells
Joseph D, von Deimling M, Risbud R, McCoy A, Marsh E
NEUROSCIENCE. 2024;558:128-150.

Diagnostic Accuracy of Liquid Biomarkers for Clinically Significant Prostate Cancer Detection: A Systematic Review and Diagnostic Meta-analysis of Multiple Thresholds
Kawada T, Shim S, Quhal F, Rajwa P, Pradere B, Yanagisawa T, Bekku K, Laukhtina E, von Deimling M, Teoh J, Karakiewicz P, Araki M, Shariat S
EUR UROL ONCOL. 2024;7(4):649-662.

Impact of Preoperative Plasma Potassium Levels on Oncological Outcomes, Major Complications, and 30-Day Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy
Klemm J, Shariat S, Laukhtina E, Rajwa P, Vetterlein M, Schuettfort V, von Deimling M, Dahlem R, Fisch M, Rink M
CLIN GENITOURIN CANC. 2024;22(3):.

Androgendeprivationstherapie und kardiovaskuläre Morbidität beim Prostatakarzinom: ein narratives Review
Klemm J, von Deimling M, Fisch M, Kramer G, Tilki D, Steuber T, von Amsberg G, Hengstenberg C, Shariat S
UROLOGE. 2024;63(3):262-268.

Urinary function in female patients after traditional, organ-sparing and nerve-sparing radical cystectomy for bladder cancer: a systematic review and pooled analysis
Laukhtina E, von Deimling M, Pradere B, Yanagisawa T, Rajwa P, Kawada T, Quhal F, Pallauf M, Bianchi A, Majdoub M, Mostafaei H, Motlagh R, Mori K, Enikeev D, Fisch M, Moschini M, D'Andrea D, Soria F, Albisinni S, Fajkovic H, Rink M, Teoh J, Gontero P, Shariat S
BJU INT. 2024;133(3):246-258.

A Territory-wide Study Investigating the Dose and Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with Intermediate- and High-risk Non-muscle-invasive Bladder Cancer
Liu K, Zhao H, Chen X, Nicoletti R, Vasdev N, Peter Ka-Fung C, Ng C, Kawada T, Laukthina E, Mori K, Yanagisawa T, D'Andrea D, von Deimling M, Albisinni S, Krajewski W, Pradere B, Soria F, Moschini M, Enikeev D, Shariat S, Kamat A, Giannarini G, Teoh J
EUR UROL ONCOL. 2024;7(3):438-446.

Role of clinicopathological variables in predicting recurrence and survival outcomes after surgery for non-metastatic renal cell carcinoma: Systematic review and meta-analysis
Majdoub M, Yanagisawa T, Quhal F, Laukhtina E, von Deimling M, Kawada T, Rajwa P, Bianchi A, Pallauf M, Mostafaei H, Chlosta M, Pradere B, Karakiewicz P, Schmidinger M, Rub R, Shariat S
INT J CANCER. 2024;154(7):1309-1323.

The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies
Miszczyk M, Rajwa P, Yanagisawa T, Nowicka Z, Shim S, Laukhtina E, Kawada T, von Deimling M, Pradere B, Rivas J, Gandaglia G, van den Bergh R, Goldner G, Supiot S, Zilli T, Trinh Q, Nguyen P, Briganti A, Ost P, Ploussard G, Shariat S
EUR UROL. 2024;85(2):125-138.

Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomy
Pichler R, Fritz J, Mari A, Cadenar A, von Deimling M, Marcq G, Del Giudice F, Leonardo C, Bologna E, Mori K, Tahbaz R, De Santis M, Klatte T, Erber B, Lackner F, Kronbichler A, Seeber A, Fisch M, Moschini M, Pradere B, Mertens L
ONCOLOGIST. 2024;29(11):e1511-e1522.

Impact of the Extent of Lymph Node Dissection on Survival Outcomes in Clinically Lymph Node-Positive Bladder Cancer
von Deimling M, Furrer M, Mertens L, Mari A, van Ginkel N, Bacchiani M, Maas M, Pichler R, Li R, Moschini M, Bianchi A, Vetterlein M, Lonati C, Crocetto F, Taylor J, Tully K, Afferi L, Soria F, Del Giudice F, Longoni M, Laukhtina E, Antonelli A, Rink M, Fisch M, Lotan Y, Spiess P, Black P, Kiss B, Pradere B, Shariat S
BJU INT. 2024;133(3):341-350.

The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancer
von Deimling M, Mertens L, Furrer M, Li R, Tendijck G, Taylor J, Crocetto F, Maas M, Mari A, Pichler R, Moschini M, Tully K, D'Andrea D, Laukhtina E, Del Giudice F, Marcq G, Velev M, Gallioli A, Albisinni S, Mori K, Khanna A, Rink M, Fisch M, Minervini A, Black P, Lotan Y, Spiess P, Kiss B, Shariat S, Pradere B
BJU INT. 2024;134(1):119-127.

Comprehensive Evaluation of the Ability of Comorbidity and Health Status Indices to Improve the Prediction of Perioperative Morbidity and Long-Term Survival Outcomes After Radical Cystectomy
von Deimling M, Rink M, Klemm J, Koelker M, Schuettfort V, König F, Gild P, Ludwig T, Marks P, Dahlem R, Fisch M, Shariat S, Vetterlein M
CLIN GENITOURIN CANC. 2024;22(2):336-346.e9.

First-line immunotherapy of metastatic renal cell carcinoma: an updated network meta-analysis including triplet therapy
Yanagisawa T, Kawada T, Bekku K, Laukhtina E, Rajwa P, von Deimling M, Chlosta M, Quhal F, Pradere B, Karakiewicz P, Mori K, Kimura T, Shariat S, Schmidinger M
BJU INT. 2024;134(3):323-336.

Repeat Transurethral Resection for Non-muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary Era
Yanagisawa T, Kawada T, von Deimling M, Bekku K, Laukhtina E, Rajwa P, Chlosta M, Pradere B, D'Andrea D, Moschini M, Karakiewicz P, Teoh J, Miki J, Kimura T, Shariat S
EUR UROL FOCUS. 2024;10(1):41-56.

Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyond
Bianchi A, von Deimling M, Pallauf M, Yanagisawa T, Kawada T, Mostafaei H, Quhal F, Laukhtina E, Rajwa P, Majdoub M, Sari Motlagh R, Pradère B, Karakiewicz P, Cerruto M, Antonelli A, Shariat S
EXPERT OPIN PHARMACO. 2023;24(2):177-195.

Oncologic and Safety Outcomes for Endoscopic Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An Updated Systematic Review and Meta-analysis
Kawada T, Laukhtina E, Quhal F, Yanagisawa T, Rajwa P, Pallauf M, von Deimling M, Bianchi A, Pradère B, Fajkovic H, Enikeev D, Gontero P, Roupret M, Seisen T, Araki M, Shariat S
EUR UROL FOCUS. 2023;9(2):236-240.

The efficacy and safety outcomes of lower dose BCG compared to intravesical chemotherapy in non-muscle-invasive bladder cancer: A network meta-analysis
Kawada T, Yanagisawa T, Bekku K, Laukhtina E, von Deimling M, Chlosta M, Pradere B, Teoh J, Babjuk M, Araki M, Shariat S
UROL ONCOL-SEMIN ORI. 2023;41(6):261-273.

Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysis
Kawada T, Yanagisawa T, Bekku K, Laukhtina E, von Deimling M, Majdoub M, Chlosta M, Pradere B, Babjuk M, Gontero P, Moschini M, Araki M, Shariat S
IMMUNOTHERAPY-UK. 2023;15(12):933-943.

Impact of Performance Status on Oncologic Outcomes in Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitor: A Systematic Review and Meta-analysis
Kawada T, Yanagisawa T, Mostafaei H, Sari Motlagh R, Quhal F, Rajwa P, Laukhtina E, von Deimling M, Bianchi A, Majdoub M, Pallauf M, Pradere B, Teoh J, Karakiewicz P, Araki M, Shariat S
EUR UROL FOCUS. 2023;9(2):264-274.

Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized Reporting
Klemm J, Rink M, von Deimling M, Koelker M, Gild P, Shariat S, Dahlem R, Fisch M, Vetterlein M
EUR UROL FOCUS. 2023;9(6):1072-1076.

Rational peri-operative management of antithrombotic therapy in patients undergoing radical cystectomy: A 30-day morbidity analysis based on the updated European Association of Urology guidelines for standardized complication reporting
Koelker M, Bradtke M, Klemm J, von Deimling M, Gild P, Dahlem R, Fisch M, Rink M, Vetterlein M
EJSO-EUR J SURG ONC. 2023;49(12):107123.

Oncologic and Safety Outcomes for Retrograde and Antegrade Endoscopic Surgeries for Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis
Laukhtina E, Kawada T, Quhal F, Yanagisawa T, Rajwa P, von Deimling M, Pallauf M, Bianchi A, Majdoub M, Enikeev D, Fajkovic H, Teoh J, Rouprêt M, Gontero P, Shariat S
EUR UROL FOCUS. 2023;9(2):258-263.

For Which Patients Should Bladder Preservation Be Considered After a Complete Response to Neoadjuvant Chemotherapy
Laukhtina E, Quhal F, von Deimling M, Kawada T, Yanagisawa T, Rajwa P, Majdoub M, Enikeev D, Shariat S
EUR UROL FOCUS. 2023;9(6):900-902.

Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinoma
von Deimling M, D'Andrea D, Pradere B, Laukhtina E, Yanagisawa T, Kawada T, Majdoub M, Rajwa P, Pallauf M, Singla N, Soria F, Margulis V, Chlosta P, Karakiewicz P, Roupret M, Teoh J, Fisch M, Rink M, Moschini M, Lotan Y, Shariat S
WORLD J UROL. 2023;41(7):1861-1868.

Carboplatin Induction Chemotherapy in Clinically Lymph Node-positive Bladder Cancer
von Deimling M, Mertens L, van Rhijn B, Lotan Y, Spiess P, Daneshmand S, Black P, Pallauf M, D'Andrea D, Moschini M, Soria F, Del Giudice F, Afferi L, Laukhtina E, Yanagisawa T, Kawada T, Teoh J, Abufaraj M, Ploussard G, Roumiguié M, Karakiewicz P, Babjuk M, Gontero P, Xylinas E, Rink M, Shariat S, Pradere B
EUR UROL OPEN SCI. 2023;51:39-46.

Oncological validation and discriminative ability of pentafecta criteria after open radical cystectomy
von Deimling M, Rink M, Klemm J, Koelker M, König F, Gild P, Khonsari M, Ludwig T, Marks P, Dahlem R, Fisch M, Vetterlein M
BJU INT. 2023;131(1):90-100.

Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy
von Deimling M, Schuettfort V, D'Andrea D, Pradere B, Grossmann N, Kawada T, Yanagisawa T, Majdoub M, Laukhtina E, Rajwa P, Quhal F, Mostafaei H, Fajkovic H, Teoh J, Moschini M, Karakiewicz P, Fisch M, Rink M, Shariat S
CLIN GENITOURIN CANC. 2023;21(4):430-441.

Impact of performance status on efficacy of systemic therapy for prostate cancer: a meta-analysis
Yanagisawa T, Kawada T, Mori K, Shim S, Mostafaei H, Sari Motlagh R, Quhal F, Laukhtina E, von Deimling M, Bianchi A, Majdoub M, Pallauf M, Pradere B, Kimura T, Shariat S, Rajwa P
BJU INT. 2023;132(4):365-379.

Role of pelvic drain and timing of urethral catheter removal following RARP: a systematic review and meta-analysis
Yanagisawa T, Kawada T, Mostafaei H, Sari Motlagh R, Quhal F, Laukhtina E, Rajwa P, von Deimling M, Bianchi A, Pallauf M, Pradere B, Karakiewicz P, Miki J, Kimura T, Shariat S
BJU INT. 2023;132(2):132-145.

Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis
Yanagisawa T, Kawada T, Quhal F, Bekku K, Laukhtina E, Rajwa P, von Deimling M, Majdoub M, Chlosta M, Pradere B, Mori K, Kimura T, Schmidinger M, Karakiewicz P, Shariat S
WORLD J UROL. 2023;41(7):1763–1774.

Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023
Yanagisawa T, Kawada T, von Deimling M, Laukhtina E, Kimura T, Shariat S
CURR OPIN UROL. 2023;33(4):258-268.

Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: a meta-analysis
Yanagisawa T, Quhal F, Kawada T, Bekku K, Laukhtina E, Rajwa P, von Deimling M, Chlosta M, Pradere B, Karakiewicz P, Mori K, Kimura T, Schmidinger M, Shariat S
IMMUNOTHERAPY-UK. 2023;15(15):1309-1322.

Oncological impact of cystoscopic findings in non-muscle-invasive bladder cancer
Yanagisawa T, Quhal F, Kawada T, Mostafaei H, Sari Motlagh R, Laukhtina E, Rajwa P, von Deimling M, Bianchi A, Pallauf M, Majdoub M, Pradère B, Abufaraj M, Moschini M, Karakiewicz P, Iwatani K, Miki J, Kimura T, Shariat S
BJU INT. 2023;131(6):643-659.

A Systematic Review and Meta-analysis of Chemoablation for Non-muscle-invasive Bladder Cancer
Yanagisawa T, Quhal F, Kawada T, Mostafaei H, Sari Motlagh R, Laukthina E, Rajwa P, von Deimling M, Bianchi A, Pallauf M, Majdoub M, Pradere B, Moschini M, Karakiewicz P, Teoh J, Miki J, Kimura T, Shariat S
EUR UROL FOCUS. 2023;9(3):463-479.

An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer
Yanagisawa T, Rajwa P, Kawada T, Bekku K, Laukhtina E, von Deimling M, Majdoub M, Chlosta M, Karakiewicz P, Heidenreich A, Kimura T, Shariat S
CURR ONCOL. 2023;30(2):2194-2216.

Efficacy of Systemic Treatment in Prostate Cancer Patients With Visceral Metastasis: A Systematic Review, Meta-analysis, and Network Meta-analysis
Yanagisawa T, Rajwa P, Kawada T, Mori K, Fukuokaya W, Petrov P, Quhal F, Laukhtina E, von Deimling M, Bianchi A, Majdoub M, Pradere B, Kramer G, Kimura T, Shariat S
J UROLOGY. 2023;210(3):416-429.

Neoadjuvant Androgen Receptor Signaling Inhibitors before Radical Prostatectomy for Non-Metastatic Advanced Prostate Cancer: A Systematic Review
Yanagisawa T, Rajwa P, Quhal F, Kawada T, Bekku K, Laukhtina E, von Deimling M, Chlosta M, Karakiewicz P, Kimura T, Shariat S
J PERS MED. 2023;13(4):.

Urinary Diversion With or Without Concomitant Cystectomy for Benign Conditions: A Comparative Morbidity Assessment According to the Updated European Association of Urology Guidelines on Reporting and Grading of Complications
Vetterlein M, Buhné M, Yu H, Klemm J, von Deimling M, Gild P, Koelker M, Dahlem R, Fisch M, Soave A, Rink M
EUR UROL FOCUS. 2022;8(6):1831-1839.

Radical cystectomy and urinary diversion in women: techniques, outcomes, and challenges—a narrative review
von Deimling M, Laukhtina E, Pradere B, Pallauf M, Klemm J, Fisch M, Shariat S, Rink M
TRANSL ANDROL UROL. 2022;11(11):1598-1610.

Active surveillance for non-muscle-invasive bladder cancer: fallacy or opportunity?
von Deimling M, Pallauf M, Bianchi A, Laukhtina E, Karakiewicz P, Rink M, Shariat S, Pradere B
CURR OPIN UROL. 2022;32(5):567-574.

The current role of precision surgery in oligometastatic prostate cancer
von Deimling M, Rajwa P, Tilki D, Heidenreich A, Pallauf M, Bianchi A, Yanagisawa T, Kawada T, Karakiewicz P, Gontero P, Pradere B, Ploussard G, Rink M, Shariat S
ESMO OPEN. 2022;7(6):100597.

Protocol for isolating young adult parvalbumin interneurons from the mouse brain for extraction of high-quality RNA
Joseph D, von Deimling M, Hasegawa Y, Cristancho A, Risbud R, McCoy A, Marsh E
STAR PROTOC. 2021;2(3):100714.

Postnatal Arx transcriptional activity regulates functional properties of PV interneurons
Joseph D, von Deimling M, Hasegawa Y, Cristanco A, Ahrens-Nicklas R, Rogers S, Risbud R, McCoy A, Marsh E
ISCIENCE. 2021;24(1):101999.

Epileptic Encephalopathies as Neurodegenerative Disorders
Helbig I, von Deimling M, Marsh E
2017. Neurodegenerative Diseases. .

Gene expression analysis in untreated absence epilepsy demonstrates an inconsistent pattern
von Deimling M, Häsler R, Steinbach V, Holterhus P, von Spiczak S, Stephani U, Helbig I, Muhle H
EPILEPSY RES. 2017.

Epileptic Encephalopathies-Clinical Syndromes and Pathophysiological Concepts
von Deimling M, Helbig I, Marsh E
CURR NEUROL NEUROSCI. 2017.

Letzte Aktualisierung aus dem FIS: 21.05.2025 - 00:34 Uhr